Tag Archive
000
2011
Australia
Auto Industry
Autos
Banking
Banks
Bonds
Britain
China
Commodities
Consumer
Consumer demand
Debt
dollar
Earnings
Economy
Energy
Euro
Europe
European equities
European markets
Financial
France
Germany
Greece
Inflation
Italian
Labor
Merkel
Mining
Obama
Oil
Preview
Real Estate
Recession
Recovery
Retail
Spain
Stocks
Switzerland
Technology
U.S. equities
U.S. markets
Unemployment
FDA Rejection Could Damage Savients Credibility – US-FOREX.US
Savient Pharmaceuticals has said the Food and Drug Administration declined to approve its drug Krystexxa, for chronic gout. Approval was widely expected, and the news could shake Wall Street’s faith in the tiny company. Savient Pharmaceuticals says the FDA wants it to figure out how to explain Krystexxa’s risks to patients, which include severe allergic… »